famili
coronavirida
compris
envelop
posit
sens
rna
virus
infect
mammal
member
subfamili
coronavirina
torovirina
bird
coronavirina
fish
torovirina
coronavirus
zoonot
potenti
transmiss
anim
coronavirus
genu
betacoronaviru
human
result
novel
sever
respiratori
diseas
outbreak
sever
acut
respiratori
syndrom
sar
caus
sarsrel
coronaviru
sarscov
southern
china
subsequ
global
spread
associ
almost
death
vast
major
case
occur
asia
although
new
sar
case
observ
anoth
sever
respiratori
diseas
caus
new
betacoronaviru
emerg
middl
east
respiratori
syndrom
mer
caus
mersrel
coronaviru
merscov
far
diagnos
patient
respons
major
case
document
middl
east
viru
like
sarscov
introduc
countri
via
air
travel
mer
outbreak
south
korea
associ
importantli
merscov
still
endem
middl
east
viru
may
pandem
potenti
therefor
import
devis
novel
antivir
strategi
combat
mer
merscov
spike
protein
merss
insert
viral
envelop
mediat
viral
entri
target
cell
merss
bind
cellular
receptor
dipeptidyl
peptidas
via
surfac
unit
employ
transmembran
unit
fuse
viral
membran
host
cell
membran
allow
deliveri
viral
genom
host
cell
cytoplasm
howev
receptor
bind
alon
suffici
proteindriven
entri
protein
synthes
inact
precursor
convert
activ
form
upon
cleavag
host
cell
fact
proteolyt
process
merss
might
suffici
trigger
membran
fusion
reaction
subsequ
refer
activ
host
cell
proteas
respons
merss
activ
constitut
potenti
target
antivir
intervent
identif
cleavag
site
might
instruct
gener
inhibitor
therefor
proteolyt
activ
merss
focu
ongo
research
endeavour
follow
host
cell
proteas
activ
merss
cell
cultur
cathepsin
endosom
phdepend
cystein
proteas
proprotein
convertas
express
golgi
apparatu
lesser
extent
cell
surfac
type
ii
transmembran
serin
proteas
believ
process
protein
substrat
close
cell
surfac
express
target
cell
render
merssdriven
entri
independ
activ
cathepsin
indic
viral
entri
merscov
make
contact
compart
like
plasma
membran
traffick
cathepsin
lposit
endosom
cleavag
protein
golgi
apparatu
infect
cell
propos
essenti
subsequ
merss
activ
furin
entri
target
cell
may
endow
protein
suffici
structur
flexibl
engag
proteas
notabl
activ
cathepsin
l
might
import
viral
spread
host
thu
cathepsin
l
found
express
high
level
respiratori
inhibitor
activ
reduc
sarscov
spread
pathogenesi
rodent
model
cathepsin
l
inhibitor
littl
moreov
activ
cathepsin
l
suggest
cell
cultur
adapt
least
context
human
coronavirus
final
contribut
furin
merss
activ
host
remain
determin
context
noteworthi
one
studi
question
whether
cleavag
furin
contribut
merscov
infect
cell
anoth
show
furin
involv
protein
activ
host
cell
activ
merss
host
cell
proteas
requir
protein
process
defin
site
merss
harbor
two
cleavag
site
found
cov
protein
site
compos
amino
acid
rsvr
locat
border
subunit
site
compos
amino
acid
rsar
locat
upstream
put
fusion
peptid
present
within
subunit
fig
site
believ
process
furin
infect
site
process
viral
entri
protein
activ
proteas
identifi
today
sinc
gener
free
nterminu
fusion
peptid
requir
membran
fusion
final
afnh
motif
locat
site
site
report
requir
proteindriven
host
cell
entri
believ
process
cathepsin
howev
direct
evid
merss
activ
depend
protein
process
cathepsin
l
andor
site
frequent
lack
instanc
site
requir
protein
activ
unknown
moreov
larg
unclear
whether
certain
protein
activ
proteas
use
auxiliari
site
case
andor
avail
perform
mutagen
analysi
defin
contribut
specif
cleavag
site
merssdriven
entri
cell
line
express
defin
protein
activ
proteas
moreov
use
inhibitor
investig
proteas
choic
found
requir
intact
site
merssmedi
entri
cell
type
depend
integr
site
univers
requir
contrast
mutat
propos
cathepsin
l
site
impact
proteindriven
entri
obtain
evid
proteas
use
auxiliari
site
protein
activ
avail
final
result
compat
concept
site
process
proprotein
convertas
site
cleav
first
investig
whether
cathepsin
l
cleavag
site
fig
univers
requir
merssdriven
entri
requir
entri
certain
target
cell
use
set
previous
establish
protein
vsvbase
pseudotyp
system
mutant
ssvr
asva
harbor
alter
site
alter
mutant
nyt
previous
shown
abrog
protein
activ
cathepsin
mutant
asaa
contain
mutat
site
fig
moreov
mutant
asva
asaa
site
alter
fig
next
employ
previous
describ
vsvbase
pseudotyp
investig
mutat
introduc
merss
modul
viral
entri
first
analyz
protein
incorpor
vsv
particl
produc
cell
immunoblot
analysi
reveal
protein
mutant
studi
effici
incorpor
vsv
particl
although
variat
incorpor
effici
observ
experi
mutat
site
larg
abrog
proteolyt
process
protein
particl
produc
cell
fig
next
select
target
cell
analysi
merssdriven
entri
human
colonderiv
cell
line
human
adren
glandderiv
cell
line
either
untransfect
transfect
express
high
level
well
african
green
monkey
kidneyderiv
cell
line
vero
chosen
analysi
sinc
cell
previous
report
suscept
merssdriven
entri
vero
cell
known
allow
amplif
authent
quantit
rtpcr
analysi
vero
cell
well
human
lung
tissu
natur
target
merscov
infect
reveal
vero
lung
tissu
express
roughli
compar
amount
mrna
express
cell
elev
fig
contrast
appreci
level
mrna
detect
cell
lung
tissu
fig
keep
publish
final
mrna
cathepsin
l
well
furin
readili
detect
cell
line
test
lung
tissu
fig
thu
cell
line
studi
posit
merscov
receptor
express
differ
proteas
known
use
merss
activ
express
proteas
robust
lung
tissu
cell
line
studi
readili
suscept
transduct
control
particl
bear
vsvg
larg
refractori
transduct
particl
bear
viral
glycoprotein
fig
b
expect
transduct
mediat
wildtyp
merss
compar
vero
cell
cp
gener
higher
compar
untransfect
cell
cp
fig
howev
cell
previous
transfect
express
plasmid
transduct
level
high
vero
cell
fig
transduct
target
cell
particl
bear
merss
reveal
alter
site
markedli
reduc
entri
approx
reduct
vero
cell
fig
contrast
intact
site
univers
requir
protein
driven
entri
although
effect
observ
upon
transduct
vero
less
pronounc
seen
cell
fig
roughli
reduct
compar
reduct
cell
line
test
final
mutat
cathepsin
l
site
contrari
publish
impact
proteindriven
entri
cell
line
studi
next
determin
whether
site
cleav
proteas
exhibit
cleavag
specif
enzym
recogn
differ
cleavag
site
thu
site
contain
rxxr
motif
prerequisit
cleavag
proprotein
convertas
could
thu
process
furin
relat
enzym
altern
site
might
cleav
proteas
motif
encompass
singl
arginin
residu
suffici
cleavag
potenti
cathepsin
l
order
discern
two
possibl
investig
entri
driven
protein
mutant
either
one
arginin
mutat
employ
vero
cell
target
immunoblot
reveal
merss
mutant
effici
incorpor
vsv
particl
fig
none
mutat
introduc
site
markedli
reduc
entri
vero
cell
fig
keep
find
state
although
reduct
observ
set
experi
statist
signific
note
averag
three
experi
shown
fig
averag
nine
experi
shown
fig
contrast
mutat
singl
arginin
within
site
suffici
reduc
entri
cell
fig
suggest
site
process
proteas
depend
presenc
two
arginin
like
furin
furthermor
second
first
arginin
within
site
suffici
effici
proteindriven
entri
cell
mutat
singl
arginin
site
minor
although
statist
signific
effect
proteinmedi
transduct
vero
cell
fig
result
suggest
vero
cell
site
mainli
process
proteas
requir
singl
arginin
cleavag
site
like
see
cathepsin
l
vero
analys
far
suggest
cleavag
requir
robust
merssdriven
entri
cell
express
therefor
next
ask
whether
cleavag
site
also
requir
proteindriven
entri
cell
pathway
oper
block
merssdriven
entri
cell
cathepsin
l
inhibitor
ask
whether
blockad
overcom
express
entri
driven
merss
wt
protein
variant
mutat
site
inhibit
least
treatment
entri
driven
merss
wt
fulli
rescu
direct
express
target
cell
fig
entri
mediat
protein
mutant
inactiv
site
also
rescu
although
reduc
effici
compar
merss
wt
fig
indic
precleavag
absolut
prerequisit
subsequ
protein
activ
contrast
mutat
site
abrog
merss
activ
moreov
analysi
merss
cleavag
ci
set
ie
proteas
protein
express
cell
show
mutat
site
result
aberr
cleavag
product
compar
merss
wt
protein
mutant
alter
site
fig
final
ask
whether
residu
entri
cell
observ
upon
mutat
site
depend
cathepsin
l
activ
suggest
previou
promot
preincub
cell
proteas
inhibitor
show
entri
driven
protein
lack
intact
site
depend
cathepsin
l
activ
fig
indic
domin
role
proteindriven
host
cell
entri
cell
sum
data
suggest
intact
site
promot
essenti
merssactiv
found
simultan
inactiv
site
markedli
reduc
entri
cell
depend
modestli
reduc
proteindriven
vero
cell
depend
cathepsin
l
activ
fig
latter
find
rais
question
whether
residu
entri
vero
cell
still
depend
cathepsin
l
activ
address
question
analyz
transduct
vero
cell
preincub
cathepsin
l
inhibitor
inhibitor
camostat
camostat
reduc
proteindriven
entri
expect
contrast
cell
entri
driven
protein
analyz
compar
reduc
upon
treatment
fig
remark
cathepsin
l
depend
also
observ
mutant
inactiv
indic
cathepsin
l
unlik
employ
auxiliari
cleavag
site
protein
activ
merscov
infect
associ
casefat
rate
viru
pandem
therefor
identif
therapeut
target
import
cellular
proteas
respons
protein
activ
candid
howev
cell
line
specif
differ
proteas
choic
site
merss
process
proteas
fulli
elucid
data
support
concept
precleavag
merss
site
furin
promot
subsequ
protein
activ
howev
precleavag
essenti
protein
activ
cell
entri
driven
merss
variant
lack
precleavag
still
depend
moreov
result
suggest
site
specif
second
arginin
import
effici
protein
activ
indic
cathepsin
l
employ
altern
site
protein
activ
collect
result
advanc
understand
proteas
facilit
protein
activ
cleavag
site
within
protein
employ
rhabdovir
pseudotyp
system
studi
merssdriven
entri
target
cell
system
relat
one
previous
shown
adequ
mirror
import
aspect
cov
entri
target
cell
allow
studi
process
without
need
work
infecti
wt
protein
protein
mutant
analyz
readili
incorpor
vsv
particl
although
variat
particl
prepar
observ
uncleav
well
cleav
form
protein
detect
particl
except
mutant
alter
site
exclus
incorpor
uncleav
protein
thu
alter
cathepsin
l
site
compat
particl
incorpor
protein
mutat
site
abrog
protein
process
particl
produc
cell
analysi
merssdriven
entri
well
character
cell
line
employ
two
vero
cell
permiss
merscov
cell
line
analyz
well
lung
tissu
express
cathepsin
l
furin
mrna
keep
previous
document
broad
express
although
cathepsin
l
level
vero
cell
rel
low
contrast
robust
level
mrna
found
cell
lung
tissu
agreement
publish
final
cell
line
lung
tissu
posit
mrna
cell
express
highest
level
transfect
express
plasmid
reveal
low
amount
endogen
cell
limit
effici
protein
driven
entri
sum
well
character
particl
well
cell
line
employ
studi
contribut
potenti
cleavag
site
merss
proteolyt
activ
protein
analysi
protein
mutant
demonstr
alter
motif
markedli
inhibit
entri
cell
cell
line
studi
requir
robust
cell
entri
perhap
unexpect
sinc
cell
express
previou
studi
report
furinmedi
cleavag
viru
produc
cell
requir
subsequ
protein
activ
entri
target
find
gener
support
concept
suggest
certain
aspect
need
reconsid
thu
hand
precleavag
promot
essenti
subsequ
protein
activ
although
state
level
transient
transfect
cell
examin
might
exceed
lung
tissu
moreov
residu
entri
mutant
cell
facilit
cathepsin
l
one
would
expect
previou
work
remain
depend
whether
discrep
reflect
cell
line
specif
differ
remain
determin
context
noteworthi
cell
entri
driven
protein
sarscov
also
reli
entri
driven
glycoprotein
ebola
viru
known
depend
cathepsin
b
cathepsin
l
block
cathepsin
bl
inhibitor
data
shown
thu
activ
cathepsin
l
seem
express
cell
final
result
suggest
second
arginin
site
might
essenti
merss
activ
sinc
mutat
residu
markedli
reduc
proteindriven
entri
cell
mutat
first
arginin
diminish
entri
effici
effici
merssdriven
entri
vero
cell
facilit
cathepsin
l
larg
independ
site
requir
intact
site
keep
cleavag
site
requir
liber
nterminu
fusion
peptid
subunit
howev
sever
point
noteworthi
regard
find
first
mutat
previous
propos
cathepsin
l
cleavag
merss
diminish
viral
entri
site
alter
contain
consensu
signal
attach
nlink
glycan
previous
shown
abrog
usag
exclud
newli
introduc
glycosyl
signal
use
cell
line
employ
particl
product
howev
product
mutant
cell
result
entri
phenotyp
data
shown
suggest
differenti
nglycosyl
might
account
discrep
result
present
studi
publish
work
second
seem
effect
site
mutat
slightli
profound
entri
compar
cell
analyz
may
suggest
high
level
receptor
express
might
reduc
requir
proteolyt
activ
howev
conclus
entir
specul
third
noteworthi
vero
cell
entri
driven
protein
mutant
alter
site
moder
reduc
vero
cell
entri
remain
cathepsin
l
depend
suggest
cathepsin
l
use
auxiliari
potenti
also
site
protein
activ
find
recent
also
document
natur
site
remain
determin
employ
pcaggsbas
express
plasmid
encod
vesicular
stomat
viru
vsv
glycoprotein
vsvg
wildtyp
wt
merss
cleavag
site
mutant
ssvr
asva
nyt
asaa
asva
asaa
describ
addit
merssprotein
contain
singl
amino
acid
exchang
cleavag
site
border
asvr
rsva
site
asar
rsaa
gener
overlap
extens
pcr
protein
mutant
summar
fig
protein
construct
version
without
ctermin
tag
gener
express
plasmid
human
human
ntermin
link
dsred
dsred
pcrbase
method
insert
respect
open
read
frame
pqcxip
vector
case
express
vector
vector
encod
select
marker
puromycin
resist
exchang
blasticidin
resist
taken
vector
integr
pcramplifi
sequenc
verifi
autom
sequenc
analysi
microsynth
seqlab
human
vero
african
green
monkey
cell
cultiv
dulbecco
modifi
eagl
medium
dmem
pan
biotech
human
colorect
adenocarcinoma
cell
line
grown
minimum
essenti
media
mem
life
technolog
media
supplement
fetal
bovin
serum
fb
pan
biotech
well
penicillin
streptomycin
stock
solut
pan
biotech
cell
incub
humidifi
atmospher
transfect
cell
perform
calciumphosph
precipit
test
proteas
facilit
merss
activ
target
cell
preincub
cathepsin
l
inhibitor
sigmaaldrich
serin
proteas
inhibitor
camostat
sigmaaldrich
h
cell
inocul
transduct
vector
follow
antibodi
use
primari
antibodi
anti
invitrogen
anti
sigmaaldrich
anti
vsvm
kerafast
secondari
antibodi
antimous
hrp
hors
radish
peroxidas
conjug
antibodi
employ
dianova
antibodi
dilut
phosphat
buffer
salin
contain
pb
skim
milk
employ
previous
describ
protocol
vsvpp
brief
cell
transfect
express
plasmid
wild
type
wt
mutant
merss
vsvg
posit
control
empti
express
vector
neg
control
h
post
transfect
cell
inocul
vsv
indiana
strain
kindli
provid
g
zimmer
h
next
inoculum
remov
cell
wash
pb
standard
cultur
media
contain
anti
vsvg
antibodi
produc
hybridoma
cell
atcc
ad
cell
except
transfect
vsvg
express
vector
cell
incub
h
vsvppcontain
supernat
harvest
clear
cellular
debri
centrifug
g
min
either
store
directli
use
transduct
experi
latter
target
cell
grown
plate
necessari
cell
previous
transfect
express
plasmid
dsred
andor
h
advanc
andor
pretreat
proteas
inhibitor
h
advanc
transduct
cultur
medium
aspir
vsvpp
ad
cell
transduct
effici
quantifi
measur
viru
encod
firefli
luciferas
fluc
activ
cell
lysat
use
commerci
kit
pjk
plate
luminomet
hidex
cell
transfect
express
plasmid
wt
mutant
merss
harbor
c
termin
tag
analys
focus
protein
activ
cell
cotransfect
plasmid
respect
merss
construct
investig
protein
express
target
cell
whole
cell
lysat
wcl
prepar
lyse
cell
sdssampl
buffer
trishcl
glycerol
sd
betamercaptoethanol
bromophenolblu
mm
edta
case
incorpor
protein
vsvpp
investig
vsvpp
present
cell
cultur
supernat
pellet
high
speed
centrifug
g
h
sucros
cushion
lyse
sdssampl
buffer
follow
sdspage
reduc
condit
protein
transfer
onto
nitrocellulos
membran
hartenstein
block
min
skim
milk
pbst
incub
antibodi
target
tag
protein
actin
wcl
load
control
vsvm
vsvpp
load
control
combin
hrpconjug
secondari
antibodi
dianova
western
blot
develop
use
selfmad
chemiluminesc
reagent
combin
chemocam
imag
system
chemostar
profession
softwar
inta
scienc
imag
instrument
rel
transcript
level
furin
cathepsin
l
determin
quantit
pcr
qpcr
total
rna
extract
vero
cell
use
rneasi
mini
kit
qiagen
gmbh
accord
manufactur
instruct
afterward
rna
dnasetr
new
england
biolab
subsequ
revers
transcrib
cdna
use
iii
firststrand
synthesi
system
thermo
fisher
scientif
follow
manufactur
specif
addit
commerci
avail
cdna
takara
isol
human
lung
tissu
analyz
qpcr
perform
cdnareact
employ
quantitect
green
pcr
kit
qiagen
gmbh
rotor
q
qiagen
gmbh
platform
sampl
measur
triplic
serial
dilut
express
vector
actb
housekeep
gene
control
furin
cathepsin
l
contain
copiesreact
measur
use
gener
standard
curv
actb
target
calcul
respect
copi
number
normal
target
copi
number
divid
actb
copi
number
display
target
gene
copi
per
copi
actb
